BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Queensland Health
Accenture
Express Scripts
Federal Trade Commission
Baxter
Chinese Patent Office
US Army
Cantor Fitzgerald
Fish and Richardson

Generated: January 22, 2018

DrugPatentWatch Database Preview

CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF Drug Profile

« Back to Dashboard

Which patents cover Children's Cetirizine Hydrochloride Hives Relief, and when can generic versions of Children's Cetirizine Hydrochloride Hives Relief launch?

Children's Cetirizine Hydrochloride Hives Relief is a drug marketed by Actavis Mid Atlantic, Allied Pharma Inc, Amneal Pharms, Apotex Inc, Aurobindo Pharma, Bio Pharm Inc, Cypress Pharm, Perrigo R And D, Ranbaxy Labs Ltd, Silarx, Taro, Tris Pharma Inc, Jubilant Generics, and Sun Pharma Global. and is included in fifteen NDAs.

The generic ingredient in CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-seven suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
Drug patent expirations by year for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
Medical Subject Heading (MeSH) Categories for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF

US Patents and Regulatory Information for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090378-001 May 9, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cypress Pharm CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090300-002 Oct 10, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090188-001 Apr 22, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 201546-002 May 20, 2011 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo R And D CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090254-001 Apr 9, 2008 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharma Global CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride TABLET, CHEWABLE;ORAL 090142-003 Aug 30, 2011 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jubilant Generics CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride TABLET, CHEWABLE;ORAL 091116-003 Feb 19, 2015 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Allied Pharma Inc CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 091327-002 Oct 17, 2011 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090765-001 Oct 7, 2009 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bio Pharm Inc CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090474-001 Mar 30, 2009 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
Dow
Teva
Chubb
Accenture
Julphar
US Department of Justice
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot